Sergey Nejentsev
professorMale0.0Global Dominance: 0.00%
Professor Sergey Nejentsev is a leading researcher at the University of Cambridge who was instrumental in identifying the genetic cause of Activated PI3-kinase Delta Syndrome (APDS). He expressed excitement over the recent approval of leniolisib, a drug that targets the condition, marking a significant step forward in treatment options for affected patients.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Prof Sergey Nejentsev from the University of Cambridge who led the research that discovered APDS said: 'As soon as we understood the cause of APDS, we immediately realised that certain drugs could be used to inhibit the enzyme that is activated in these patients.'
New drug offers potential cure for ultra rare inherited conditionBBC·
United Kingdom· 2025-06-27
United Kingdom· 2025-06-27
